Let's Discuss Your Immunotherapy Needs
Connect with Cellicure's team to explore cell-based solutions for cancer and inflammatory diseases.
Reach Cellicure in Germantown
Contact us directly to discuss collaborations, partnerships, or inquiries about our NK cell immunotherapy programs. We're ready to connect.
Send us a message
Have questions about our NK cell therapies or want to explore collaboration opportunities? Fill out the form below and our team will respond promptly.
Frequently asked questions
Find answers about Cellicure's NK cell therapies, our technology, and how to work with us.
What is Cellicure's Effic-NK™ expansion system?
Effic-NK™ is our proprietary feeder-free NK cell expansion platform. It produces high-yield natural killer cells with intact functionality, enabling rapid scale-up without the complexity of traditional culture methods.
How does Saftein™ technology improve NK cell therapy?
Saftein™ is a membrane-bound technology that enhances NK cell survival and renewal. Unlike cytokine-based approaches, it delivers superior cell persistence without causing toxicity or immunosuppression.
What diseases does Cellicure focus on?
We develop cell-based immunotherapies for solid tumors, hematological cancers, and chronic inflammatory diseases. Our approach targets highly unmet clinical needs with innovative NK cell treatments.
Can Cellicure's therapies work with existing cancer treatments?
Cellicure's NK cell products are designed to complement current treatment approaches. Our therapies work through distinct mechanisms to enhance survival and functionality while minimizing adverse effects.
How do I inquire about collaborations or partnerships?
Contact Cellicure directly to discuss collaboration opportunities. Reach out via email or phone, and our team will connect you with the right person to explore potential partnerships.
Where is Cellicure based and who do you work with?
Cellicure is located in Germantown, Maryland, and conducts global product development and commercialization. We partner with leading organizations to advance our immunotherapy pipeline.
Still have questions?
Reach out directly to discuss how Cellicure's therapies may address your clinical or commercial interests.
Collaborations driving cellular immunotherapy forward
Cellicure partners with leading research institutions, clinical organizations, and biotech innovators to advance NK cell therapies and expand access to breakthrough treatments.
12+
Academic partnerships
Collaborations with research institutions advancing NK cell science and clinical validation.
8+
Clinical development partners
Organizations supporting Cellicure's path to bringing cell therapies to patients with cancer and inflammatory diseases.
6+
Manufacturing collaborators
Partners enabling scalable, high-yield production of Cellicure's NK cell treatments for global clinical needs.
15+
Industry network connections
Strategic relationships across biotechnology, pharma, and clinical communities accelerating immunotherapy innovation.